Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Semaglutide (SEM-a-gloo-tide) A synthetic GLP-1 receptor agonist developed from exendin-4
Nucleic Acids Res 25 , 33893402 (1997)
Diabetic macular oedema
Your GP should also review any current medications, as drug interactions can occur
Circ J (2016) 80(11):227781
doi: 10.3389/fnbeh.2026.1805953 Received 06 February 2026 Revised 13 March 2026 Accepted 13 March 2026 Published 13 April 2026 Volume 20 - 2026 Edited by Emmanuel Darcq, Institut National de la Sant et de la Recherche Mdicale (INSERM), France Reviewed by Zhe Zhao, Max Planck Florida Institute for Neuroscience (MPFI), United States Madhawi Aldhwayan, King Saud University, Saudi Arabia Updates Copyright 2026 OConnor
US$ 27.92
US$ 28.25
US$ 21.45
US$ 20.77
